Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease. - Busnadiego, Idoia; Abela, Irene A.; Frey, Pascal M.; Hofmaenner, Daniel A.; Scheier, Thomas C.; Schuepbach, Reto A.; Buehler, Philipp K.; Brugger, Silvio D.; Hale, Benjamin G. (PLoS Biology, 2022)